Citation Impact
Citing Papers
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
2008
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Risk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis
2006
Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence
2010
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Time to recurrence of atrial fibrillation influences outcome following catheter ablation
2012
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Paroxysmal Atrioventricular Block in Young Patients1
2004
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
2020
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography
2018 Standout
Atrial Fibrillation Ablation: Reaching the Mainstream
2006
Site-specific twelve-lead ECG features to identify an epicardial origin for left ventricular tachycardia in the absence of myocardial infarction
2007
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
2020
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
The Internet of Things for Health Care: A Comprehensive Survey
2015 Standout
Concentration-dependent mortality of chloroquine in overdose
2020
Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Paroxysmal atrioventricular block: clinical experience with 20 patients
2004
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
2009
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Flexible and Stretchable Physical Sensor Integrated Platforms for Wearable Human‐Activity Monitoringand Personal Healthcare
2016 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Practice Standards for Electrocardiographic Monitoring in Hospital Settings
2004
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Works of Stuart Beldner being referenced
Clinical Predictors of Appropriate Implantable‐Cardioverter Defibrillator Discharge
2007
Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: Clue to specificity of Brugada-type electrocardiographic changes
2004
Cough‐Induced Heart Block
1999
Twelve-lead electrocardiographic characteristics of the aortic cusp region guided by intracardiac echocardiography and electroanatomic mapping
2008
Is Telemetry Monitoring Necessary in Low-Risk Suspected Acute Chest Pain Syndromes?
2002
Ventricular Tachycardia/Ventricular Fibrillation Ablation in the Setting of Ischemic Heart Disease
2005
Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation
2006
Does targeted pulmonary vein isolation still have a role in atrial fibrillation ablation?
2005
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
2020